We also demonstrate that OGG1 and PARG inhibitors can exacerbate the impact of high-LET protons in tumour cell killing, and therefore could represent a novel therapeutic strategy, such as in the treatment of HNSCC. This evidence concerns the gene PARG and head and neck squamous cell carcinoma.